Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00876265 · ClinicalTrials.gov registry record · Phase 3
Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.
A Phase 3 study, sponsored by Merz North America.
- Completed
- Registry status
- Phase 3
- Development phase
- 118
- Enrollment target
NCT00876265 is a Phase 3 study that has completed, run by Merz North America. The registered enrollment target is 118 participants.
The verdict
NCT00876265, a Phase 3 study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 118 participants
- Enrollment target
Study Summary
This was a study to find out how an investigational product, Belotero, compares to a second product in people with facial wrinkles, such as nasolabial folds. Nasolabial folds are wrinkles on the face that go from the outside of the nostrils to the edges of the mouth. Additionally, this study determined Belotero is safe and tolerable and corrects facial wrinkles, such as nasolabial folds.
Interventions
- DEVICE Belotero
- DEVICE Zyplast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2006-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00876265
The ClinicalTrials.gov registry entry for NCT00876265 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Belotero is the first listed.
NCT00876265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00876265 about?
NCT00876265 is a clinical study titled "Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.". This was a study to find out how an investigational product, Belotero, compares to a second product in people with facial wrinkles, such as nasolabial folds. Nasolabial folds are wrinkles on the face that go from the outside of the nostrils to the edges of the mouth. Additionally, this study determi...
What is the current status of trial NCT00876265?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 118 participants. The study started on 2006-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00876265?
The interventions under investigation include: Belotero (DEVICE), Zyplast (DEVICE).
Who is sponsoring clinical trial NCT00876265?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.